2383. In Vitro Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017

BACKGROUND: Pseudomonas aeruginosa (PA) is an important nosocomial pathogen. Treatment options for infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) isolates remain limited. Ceftolozane-tazobactam (C/T) and ceftazidime–avibactam (CZA) are two newer antimicrobials wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Walkty, Andrew, Adam, Heather J, Baxter, Melanie, Lagace-Wiens, Philippe, Karlowsky, James, Hoban, Daryl, Zhanel, George
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255566/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados